Sex (n = 851) |
Female |
618 (72.6) |
26 (70.3) |
198 (67.8) |
136 (78.2) |
113 (69.8) |
145 (78.0) |
.1058 |
.049 |
– |
|
|
Male |
233 (27.4) |
11 (29.7) |
94 (32.2) |
38 (21.8) |
49 (30.3) |
41 (22.0) |
|
|
|
|
|
|
Age category (n = 835)
|
Young child (0–4 years) |
21 (2.5) |
3 (8.3) |
10 (3.5) |
4 (2.3) |
3 (1.9) |
1 (0.6) |
.1009 |
.005 |
Ref |
– |
– |
Child (5–11 years) |
21 (2.5) |
1 (2.8) |
16 (5.6) |
2 (1.2) |
1 (0.6) |
1 (0.6) |
|
|
.95 |
.65–1.40 |
.794 |
Adolescent (12-17 years) |
10 (1.2) |
0 (0.0) |
6 (2.1) |
1 (0.6) |
2 (1.3) |
1 (0.6) |
|
|
1.2 |
.8–2.0 |
.455 |
Working age (18–65 years) |
678 (81.2) |
31 (86.1) |
218 (76.0) |
143 (83.6) |
132 (83.0) |
154 (84.6) |
|
|
1.3 |
1.0–1.8 |
.042 |
Elderly (65 years and older) |
105 (12.6) |
1 (2.8) |
21 (12.3) |
21 (12.3) |
21 (13.2) |
25 (13.7) |
|
|
1.4 |
1.0–1.8 |
.046 |
|
Visit (n = 852)
|
First |
281 (33.0) |
11 (29.7) |
110 (37.4) |
52 (30.2) |
44 (27.5) |
64 (33.9) |
.0812 |
.229 |
– |
|
|
Follow up |
571 (67.0) |
26 (70.3) |
184 (62.6) |
120 (70.0) |
116 (72.5) |
125 (66.1) |
|
|
|
|
|
|
Chronicity (n = 844)
|
Acute |
165 (19.5) |
8 (22.9) |
82 (28.4) |
36 (20.7) |
21 (13.2) |
18 (9.6) |
.1512 |
<.001 |
Ref |
– |
– |
Chronic |
633 (75.0) |
26 (74.3) |
186 (64.4) |
128 (73.6) |
129 (81.1) |
164 (87.7) |
|
|
1.2 |
1.1–1.3 |
.003 |
Unsure |
46 (5.5) |
1 (2.9) |
21 (7.3) |
10 (5.8) |
9 (5.7) |
5 (2.7) |
|
|
1.0 |
.8–1.3 |
.767 |
|
Primary reason for visit (n = 854)
|
Musculoskeletal condition |
158 (18.4) |
13 (33.3) |
56 (19.0) |
37 (21.3) |
29 (17.8) |
23 (12.2) |
.1170 |
.019 |
.90 |
.8–1.0 |
.051 |
Gastrointestinal condition |
104 (12.1) |
6 (15.4) |
37 (12.6) |
23 (13.2) |
15 (9.2) |
23 (12.2) |
.0477 |
.745 |
– |
– |
– |
Mental health condition |
93 (10.8) |
3 (7.7) |
38 (12.9) |
23 (13.2) |
18 (11.0) |
11 (5.8) |
.0946 |
.104 |
– |
– |
– |
Wellness and condition |
57 (6.6) |
1 (2.6) |
27 (9.2) |
7 (4.0) |
12 (7.4) |
10 (5.3) |
.0885 |
.151 |
– |
– |
– |
Female reproductive condition |
51 (5.9) |
1 (2.6) |
17 (5.8) |
6 (3.5) |
12 (7.4) |
15 (7.9) |
.0738 |
.321 |
– |
– |
– |
Skin condition |
44 (5.1) |
3 (7.7) |
9 (3.1) |
13 (7.5) |
9 (5.5) |
10 (5.3) |
.0774 |
.273 |
– |
– |
– |
Respiratory condition |
43 (5.0) |
0 (0.0) |
22 (7.5) |
8 (4.6) |
5 (3.1) |
8 (4.2) |
.0930 |
.115 |
– |
– |
– |
Fertility condition |
43 (5.0) |
0 (0.0) |
11 (3.7) |
12 (6.9) |
9 (5.5) |
11 (5.8) |
.074 |
.319 |
– |
– |
– |
Neurological condition |
43 (5.0) |
1 (2.6) |
16 (5.5) |
10 (5.8) |
5 (3.1) |
11 (5.8) |
.5024 |
.670 |
– |
– |
– |
Endocrine condition |
40 (4.7) |
0 (0.0) |
6 (2.0) |
7 (4.0) |
14 (8.6) |
13 (6.9) |
.1293 |
.006 |
– |
– |
– |
Cancer-related condition |
39 (4.5) |
1 (2.6) |
13 (4.4) |
4 (2.3) |
4 (2.5) |
17 (9.0) |
.1214 |
.013 |
– |
– |
– |
Cardiovascular condition |
36 (4.2) |
2 (5.1) |
11 (3.7) |
5 (2.9) |
4 (2.5) |
14 (7.4) |
.0908 |
.132 |
– |
– |
– |
Weight management |
34 (4.0) |
2 (5.1) |
11 (3.7) |
6 (3.5) |
6 (3.7) |
9 (4.8) |
.0275 |
.957 |
– |
– |
– |
Autoimmune condition |
31 (3.6) |
2 (5.1) |
7 (2.4) |
7 (4.0) |
9 (5.5) |
6 (3.2) |
.0632 |
.488 |
– |
– |
– |
Urogenital condition |
21 (2.4) |
0 (0.0) |
7 (2.4) |
4 (2.3) |
6 (3.7) |
4 (2.1) |
.0498 |
.712 |
– |
– |
– |
Ageing or cognition condition |
10 (1.2) |
0 (0.0) |
3 (1.0) |
1 (0.6) |
4 (2.5) |
2 (1.0) |
.0630 |
.491 |
– |
– |
– |
Infectious condition |
7 (0.8) |
0 (0.0) |
2 (0.7) |
1 (0.6) |
2 (1.2) |
2 (1.0) |
.034 |
.911 |
– |
– |
– |
|
Health care team (n = 854)
|
General practitioner |
369 (43.2) |
14 (40.0) |
101 (34.5) |
78 (44.8) |
81 (47.0) |
95 (50.3) |
.1372 |
.003 |
1.1 |
1.0–1.2 |
.020 |
Specialist doctor |
237 (27.8) |
9 (25.7) |
55 (18.8) |
52 (29.9) |
54 (33.1) |
67 (35.5) |
.1538 |
<.001 |
1.1 |
1.0–1.2 |
.034 |
Allied health practitioner |
106 (12.7) |
2 (5.7) |
31 (10.6) |
26 (14.9) |
23 (14.1) |
24 (12.7) |
.0669 |
.431 |
– |
– |
– |
Other complementary medicine practitioner |
93 (10.9) |
3 (8.6) |
23 (7.9) |
20 (11.5) |
23 (14.1) |
24 (12.7) |
.0797 |
.246 |
– |
– |
– |
No other health practitioner |
282 (33.0) |
14 (40.0) |
119 (40.6) |
53 (30.5) |
43 (26.4) |
53 (28.0) |
.1294 |
.006 |
– |
– |
– |
|
Specific systems considered |
Gastrointestinal system |
348 (40.8) |
0 (0.0) |
48 (16.4) |
63 (36.2) |
99 (60.7) |
138 (73.0) |
.4912 |
<.001 |
|
|
|
Endocrine system |
203 (23.8) |
0 (0.0) |
21 (7.2) |
41 (23.6) |
46 (28.2) |
95 (50.3) |
.3909 |
<.001 |
|
|
|
Musculoskeletal system |
151 (17.7) |
0 (0.0) |
21 (7.2) |
26 (14.9) |
36 (22.1) |
68 (36.0) |
.2989 |
<.001 |
|
|
|
Female reproductive system |
134 (15.7) |
0 (0.0) |
11 (3.8) |
30 (17.2) |
29 (17.8) |
64 (33.9) |
.3175 |
<.001 |
|
|
|
Mental health |
132 (15.5) |
0 (0.0) |
29 (9.9) |
30 (17.2) |
27 (16.6) |
46 (24.3) |
.1722 |
<.001 |
|
|
|
Cardiovascular system |
108 (12.7) |
0 (0.0) |
12 (4.1) |
11 (6.3) |
27 (16.6) |
58 (30.7) |
.3223 |
<.001 |
|
|
|
Integumentary system |
79 (9.3) |
0 (0.0) |
9 (3.1) |
6 (3.5) |
15 (9.2) |
49 (25.9) |
.3182 |
<.001 |
|
|
|
Autoimmune condition |
74 (8.7) |
0 (0.0) |
3 (1.0) |
5 (2.9) |
18 (11.0) |
48 (25.4) |
.3428 |
<.001 |
|
|
|
Respiratory system |
71 (7.3) |
0 (0.0) |
7 (2.4) |
5 (2.9) |
15 (9.2) |
44 (23.3) |
.3044 |
<.001 |
|
|
|
Ageing and cognition |
69 (8.1) |
0 (0.0) |
9 (3.1) |
10 (5.8) |
13 (8.0) |
37 (19.6) |
.2368 |
<.001 |
|
|
|
Neurological system |
67 (14.3) |
0 (0.0) |
13 (4.4) |
12 (6.9) |
15 (9.2) |
27 (14.3) |
.1498 |
.001 |
|
|
|
Urogenital system |
41 (4.8) |
0 (0.0) |
4 (1.4) |
1 (0.6) |
12 (7.4) |
24 (12.7) |
.2277 |
<.001 |
|
|
|
Cancer |
29 (3.4) |
0 (0.0) |
7 (2.4) |
3 (1.7) |
0 (0.0) |
19 (10.1) |
.2021 |
<.001 |
|
|
|